Bahar Bassiri Gharb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bahar Bassiri Gharb has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
Antonio Rampazzo
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH
34 shared publications- Antonio Rampazzo
Cleveland Clinic, Cleveland, OH, USA
18 shared publications - Diane Jo
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA
11 shared publications - Ryan Khalaf
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA
10 shared publications - Abigail Meyers
Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA
8 shared publications - Francis Papay
BrainXAI Research, BrainX,LLC., Cleveland, OH, USA
8 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 213-225
Material type versus defect size in adult cranioplasty: a multi-institutional analysis of 30-day outcomes and risk prediction modeling
- 19 August 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 213-225
Open AccessMaterial type versus defect size in adult cranioplasty: a multi-institutional analysis of 30-day outcomes and risk prediction modeling
- 21 July 2026
- Published by Wiley in Microsurgery
- Vol. 46 (5) , e70269
Reconstructive Escalation and Free Flap Failure in Chronic Forearm Osteomyelitis in Bardet‐Biedl Syndrome: A Case Report
Bardet‐Biedl syndrome (BBS) is a multisystem ciliopathy with a growing range of genetic variants and well‐recognized clinical features, including visual impairment and intellectual disability. These characteristics can markedly complicate surgical planning and postoperative care. We present the challenging case of a 36‐year‐old man with BBS, chronic forearm osteomyelitis, and a large (13 × 5 cm), persistent wound that had failed conservative therapy and multiple prior microsurgical reconstructions. The patient's history was notable for hemorrhagic anemia, two failed free flaps, and concern for recurrent wound trauma based on prior hospitalizations, raising suspicion of BBS‐related physiologic limitations or behavioral factors adversely affecting wound healing. Despite these risks, the wound caused ongoing anemia and severe functional impairment, leaving amputation as the only nonreconstructive alternative. A third reconstructive attempt was undertaken using a large anterolateral thigh free flap (25 × 11 cm) with radius excision. Initial postoperative recovery was uneventful, and the wound appeared nearly healed at 6 weeks. However, delayed wound dehiscence occurred, necessitating debridement and eventual excision of the flap at postoperative week nine, leaving a residual defect. The patient ultimately underwent transhumeral amputation at his home institution without further complications. This case underscores the importance of incorporating cognitive, visual, behavioral, and social factors into reconstructive decision‐making for patients with BBS and similar syndromes. Even with adequate technical reconstruction and social support, impaired wound awareness and potential behavioral risks may jeopardize outcomes. The authors advocate for heightened attention to patient behavior and realistic functional expectations when considering reconstructive escalation, emphasizing individualized counseling and careful risk–benefit assessment in this patient population.
- 21 July 2026
- Published by Wiley in Microsurgery
- Vol. 46 (5) , e70269
Reconstructive Escalation and Free Flap Failure in Chronic Forearm Osteomyelitis in Bardet‐Biedl Syndrome: A Case Report
Bardet‐Biedl syndrome (BBS) is a multisystem ciliopathy with a growing range of genetic variants and well‐recognized clinical features, including visual impairment and intellectual disability. These characteristics can markedly complicate surgical planning and postoperative care. We present the challenging case of a 36‐year‐old man with BBS, chronic forearm osteomyelitis, and a large (13 × 5 cm), persistent wound that had failed conservative therapy and multiple prior microsurgical reconstructions. The patient's history was notable for hemorrhagic anemia, two failed free flaps, and concern for recurrent wound trauma based on prior hospitalizations, raising suspicion of BBS‐related physiologic limitations or behavioral factors adversely affecting wound healing. Despite these risks, the wound caused ongoing anemia and severe functional impairment, leaving amputation as the only nonreconstructive alternative. A third reconstructive attempt was undertaken using a large anterolateral thigh free flap (25 × 11 cm) with radius excision. Initial postoperative recovery was uneventful, and the wound appeared nearly healed at 6 weeks. However, delayed wound dehiscence occurred, necessitating debridement and eventual excision of the flap at postoperative week nine, leaving a residual defect. The patient ultimately underwent transhumeral amputation at his home institution without further complications. This case underscores the importance of incorporating cognitive, visual, behavioral, and social factors into reconstructive decision‐making for patients with BBS and similar syndromes. Even with adequate technical reconstruction and social support, impaired wound awareness and potential behavioral risks may jeopardize outcomes. The authors advocate for heightened attention to patient behavior and realistic functional expectations when considering reconstructive escalation, emphasizing individualized counseling and careful risk–benefit assessment in this patient population.
- Open Access
- 15 June 2026
- Published by Wiley in Microsurgery
- Vol. 46 (5) , e70251
Recipient Vessel Selection in Free Flap Phalloplasty: A Systematic Review and Single‐Arm Meta‐Analysis
Background: Selection of recipient vessels in phalloplasty is challenging due to the absence of adequate vessels in the immediate proximity. There is no consensus on the appropriate vessel selection. We hypothesized that recipient vessel selection in phalloplasty is associated with differences in complications and flap survival. Methods: A literature search following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines across Ovid MEDLINE/PubMed, Embase, and CENTRAL databases identified 46 articles. Collected data included demographics, surgical details, donor and recipient vessels, use of interpositional grafts, number of venous anastomoses, and outcomes. Statistical analysis followed the random‐effects model. Results: One thousand nine hundred and seventy six phalloplasty cases were identified. The deep inferior epigastric artery (DIEA) was used in 1413 cases (71.5%) and the femoral artery (FA) was used in 563 cases (28.5%). Pooled proportions of arterial and venous thrombosis were 2.0% and 2.2%, respectively. The use of an interpositional vein graft or arteriovenous loop with the FA was associated with a significantly higher arterial thrombosis rate (16.0%) compared to direct anastomosis to the FA (0.1%, p < 0.001) and to the DIEA (1.2%, p < 0.001). In the absence of vascular thrombosis, partial flap necrosis occurred significantly less often with direct anastomosis to the FA (0.6%) than with the DIEA (6.2%, p = 0.016). Conclusions: The choice of recipient vessels is an important consideration in phalloplasty flap survival. The DIEA is associated with a low thrombosis rate. However, the significantly higher proportion of thrombosis observed with the FA may be attributable to the use of an interpositional vein graft or arteriovenous loop. Despite lower thrombosis rates, the use of the DIEA was associated with a higher proportion of partial flap necrosis when vessels were patent.
- 15 June 2026
- Published by Wiley in Microsurgery
- Vol. 46 (5) , e70251
Open AccessRecipient Vessel Selection in Free Flap Phalloplasty: A Systematic Review and Single‐Arm Meta‐Analysis
Background: Selection of recipient vessels in phalloplasty is challenging due to the absence of adequate vessels in the immediate proximity. There is no consensus on the appropriate vessel selection. We hypothesized that recipient vessel selection in phalloplasty is associated with differences in complications and flap survival. Methods: A literature search following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines across Ovid MEDLINE/PubMed, Embase, and CENTRAL databases identified 46 articles. Collected data included demographics, surgical details, donor and recipient vessels, use of interpositional grafts, number of venous anastomoses, and outcomes. Statistical analysis followed the random‐effects model. Results: One thousand nine hundred and seventy six phalloplasty cases were identified. The deep inferior epigastric artery (DIEA) was used in 1413 cases (71.5%) and the femoral artery (FA) was used in 563 cases (28.5%). Pooled proportions of arterial and venous thrombosis were 2.0% and 2.2%, respectively. The use of an interpositional vein graft or arteriovenous loop with the FA was associated with a significantly higher arterial thrombosis rate (16.0%) compared to direct anastomosis to the FA (0.1%, p < 0.001) and to the DIEA (1.2%, p < 0.001). In the absence of vascular thrombosis, partial flap necrosis occurred significantly less often with direct anastomosis to the FA (0.6%) than with the DIEA (6.2%, p = 0.016). Conclusions: The choice of recipient vessels is an important consideration in phalloplasty flap survival. The DIEA is associated with a low thrombosis rate. However, the significantly higher proportion of thrombosis observed with the FA may be attributable to the use of an interpositional vein graft or arteriovenous loop. Despite lower thrombosis rates, the use of the DIEA was associated with a higher proportion of partial flap necrosis when vessels were patent.
- Open Access
- 6 June 2026
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 51 (9) , 1028.e1-1028.e14
Timeline of Functional Recovery Following Hand and Upper-Extremity Transplantation
- 6 June 2026
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 51 (9) , 1028.e1-1028.e14
Open AccessTimeline of Functional Recovery Following Hand and Upper-Extremity Transplantation
- Open Access
- 24 February 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (11) , 4335-4347
The Impact of Testosterone Supplementation on Surgical Complications in Gender-Affirming Mastectomy: A Meta-Analysis
Background: Patients seeking gender-affirming surgery are usually on hormone supplementation. We hypothesized that perioperative testosterone therapy increases hematoma following chest masculinizing surgery. Methods: Meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies with perioperative hormone status and surgical outcomes were included. Patient characteristics, testosterone use, surgical details, and outcomes were extracted. Meta-analysis and pooled analysis using aggregated patient-level data were conducted. Results: Fifteen studies were included, comprising 3,036 testosterone-treatment (TT) and 726 non-testosterone-treatment (NTT) patients. Overall complication rates were similar (11.08% vs. 9.80%; p = 0.29). Meta-analysis showed significantly higher hematoma in TT (OR 1.99, [1.19–3.34], p < 0.001). Other complications showed no significant differences: infection (OR 0.33 [0.07–1.59]), wound dehiscence (OR 0.68 [0.04–11.06]), seroma (OR 0.5 [0.15–1.57]), and venous thromboembolism (OR 0.20 [0.0–10.42]). Hematoma risk did not differ between patients who continued versus stopped testosterone (TT-C 8.73% vs. TT-S 7.80%; p = 0.54), or by cessation timing ( p = 0.60). Mixed-effects meta-regression found incision type was not a significant moderator of hematoma (QM (1) = 0.34, p = 0.56) among TT and NTT. Without stratifying by testosterone, hematoma rates were higher with limited incisions than extended incisions (11.96% vs. 6.5%; p < 0.01). Conclusions: Testosterone therapy was associated with higher postoperative hematoma rates, while perioperative cessation did not reduce hematoma or overall complications. These findings support heightened perioperative awareness and vigilance for hematoma risk in patients receiving testosterone, while decisions regarding the timing of hormone therapy initiation should be carefully weighed against established mental health benefits. Level of Evidence III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
- 24 February 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (11) , 4335-4347
Open AccessThe Impact of Testosterone Supplementation on Surgical Complications in Gender-Affirming Mastectomy: A Meta-Analysis
Background: Patients seeking gender-affirming surgery are usually on hormone supplementation. We hypothesized that perioperative testosterone therapy increases hematoma following chest masculinizing surgery. Methods: Meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies with perioperative hormone status and surgical outcomes were included. Patient characteristics, testosterone use, surgical details, and outcomes were extracted. Meta-analysis and pooled analysis using aggregated patient-level data were conducted. Results: Fifteen studies were included, comprising 3,036 testosterone-treatment (TT) and 726 non-testosterone-treatment (NTT) patients. Overall complication rates were similar (11.08% vs. 9.80%; p = 0.29). Meta-analysis showed significantly higher hematoma in TT (OR 1.99, [1.19–3.34], p < 0.001). Other complications showed no significant differences: infection (OR 0.33 [0.07–1.59]), wound dehiscence (OR 0.68 [0.04–11.06]), seroma (OR 0.5 [0.15–1.57]), and venous thromboembolism (OR 0.20 [0.0–10.42]). Hematoma risk did not differ between patients who continued versus stopped testosterone (TT-C 8.73% vs. TT-S 7.80%; p = 0.54), or by cessation timing ( p = 0.60). Mixed-effects meta-regression found incision type was not a significant moderator of hematoma (QM (1) = 0.34, p = 0.56) among TT and NTT. Without stratifying by testosterone, hematoma rates were higher with limited incisions than extended incisions (11.96% vs. 6.5%; p < 0.01). Conclusions: Testosterone therapy was associated with higher postoperative hematoma rates, while perioperative cessation did not reduce hematoma or overall complications. These findings support heightened perioperative awareness and vigilance for hematoma risk in patients receiving testosterone, while decisions regarding the timing of hormone therapy initiation should be carefully weighed against established mental health benefits. Level of Evidence III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
- 9 December 2025
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 64 (3) , 234-240
Single subciliary/subtarsal incision approach for decompression of the orbit and complex fractures, using the inferior oblique muscle as a safety guide to the medial wall of the orbit: a 25-year experience in 361 cases
- 9 December 2025
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 64 (3) , 234-240
Single subciliary/subtarsal incision approach for decompression of the orbit and complex fractures, using the inferior oblique muscle as a safety guide to the medial wall of the orbit: a 25-year experience in 361 cases
- Open Access
- 7 October 2025
- Published by Wiley in Artificial Organs
- Vol. 50 (1) , 13-29
Integrating Dialysis in Ex Situ Machine Perfusion: A Systematic Review and Meta‐Analysis of Outcomes
Background: Ex situ machine perfusion (EVMP) leads to the accumulation of metabolites and electrolytes in the perfusate. This review aimed to examine the impact of dialysis on biochemical and functional parameters during EVMP. Methods: A systematic review was conducted per PRISMA guidelines. Studies integrating dialysis in lungs, liver, pancreas, and heart EVMP, either in large animals or humans, were included. Biochemical and metabolic parameters, organ weight, inflammatory markers, and organ‐specific outcomes were extracted. Meta‐analyses and longitudinal regression were conducted. Results: Nineteen studies were included. Dialysis maintained sodium ( p = 0.17), potassium ( p = 0.75), lactate concentrations ( p = 0.3), and pH ( p = 0.1). A significant decrease was seen in chloride concentration ( p < 0.01), while calcium levels increased significantly over time in the dialysis group ( p < 0.001). Interleukin 6 was elevated in dialysis relative to the controls during porcine lung perfusion ( p < 0.05) and trended toward significance in humans ( p = 0.08). During heart perfusion, the dialysis group exhibited higher cardiac contractility, expressed as a percentage of baseline (71.2% ± 7.7 vs. 55.3% ± 8.2, p < 0.05). During liver perfusion, bile production increased significantly from baseline ( β = +1.85 IU/L/h, p < 0.001). Lung compliance was stable in the dialysis ( β = −2.34 mL/H 2 O/h, p = 0.36) and control groups ( β = +0.12 mL/H 2 O/h, p = 0.27). Conclusion: Dialysis maintained biochemical homeostasis during EVMP. Significant functional benefits were seen in cardiac EVMP and should be investigated in other organs, including appropriate control groups.
- 7 October 2025
- Published by Wiley in Artificial Organs
- Vol. 50 (1) , 13-29
Open AccessIntegrating Dialysis in Ex Situ Machine Perfusion: A Systematic Review and Meta‐Analysis of Outcomes
Background: Ex situ machine perfusion (EVMP) leads to the accumulation of metabolites and electrolytes in the perfusate. This review aimed to examine the impact of dialysis on biochemical and functional parameters during EVMP. Methods: A systematic review was conducted per PRISMA guidelines. Studies integrating dialysis in lungs, liver, pancreas, and heart EVMP, either in large animals or humans, were included. Biochemical and metabolic parameters, organ weight, inflammatory markers, and organ‐specific outcomes were extracted. Meta‐analyses and longitudinal regression were conducted. Results: Nineteen studies were included. Dialysis maintained sodium ( p = 0.17), potassium ( p = 0.75), lactate concentrations ( p = 0.3), and pH ( p = 0.1). A significant decrease was seen in chloride concentration ( p < 0.01), while calcium levels increased significantly over time in the dialysis group ( p < 0.001). Interleukin 6 was elevated in dialysis relative to the controls during porcine lung perfusion ( p < 0.05) and trended toward significance in humans ( p = 0.08). During heart perfusion, the dialysis group exhibited higher cardiac contractility, expressed as a percentage of baseline (71.2% ± 7.7 vs. 55.3% ± 8.2, p < 0.05). During liver perfusion, bile production increased significantly from baseline ( β = +1.85 IU/L/h, p < 0.001). Lung compliance was stable in the dialysis ( β = −2.34 mL/H 2 O/h, p = 0.36) and control groups ( β = +0.12 mL/H 2 O/h, p = 0.27). Conclusion: Dialysis maintained biochemical homeostasis during EVMP. Significant functional benefits were seen in cardiac EVMP and should be investigated in other organs, including appropriate control groups.
- 4 October 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 95 (6) , 698-705
A Retrospective Comparative Analysis of MD and DO Applicants' Acceptance to Plastic Surgery Residency
Background: Doctor of osteopathic medicine (DO) applicants are underrepresented in integrated plastic surgery. We hypothesized they would match at a lower rate compared to similarly qualified doctor of medicine (MD) applicants. Methods: Applications to a large integrated plastic surgery residency program with a dedicated DO position were analyzed 2020–2023. Residents and faculty scored applications on research (1–5), letters of recommendation (LOR; 1–5), and USMLE Steps 1 and 2 (>240 = 1, >250 = 2), which summed to the total score. Residency match outcomes were verified online. Logistic regression modeling was used to assess MD versus DO odds of successful applications in the full dataset and a 3:1 MD-to-DO cohort matched by USMLE, research, and LOR scores. Applications were placed into quartiles based on total scores, and successful match outcomes were compared. Results: In the full dataset (MDs = 1100, DOs = 47), MDs had significantly stronger metrics ( P < 0.05) compared to DOs. In the adjusted logistic regression of the full dataset, MDs had 9.56 times the odds of success compared to DOs (95% CI, 3.84–27.62; P < 0.01). In the matched cohort, MDs had 5.89 times the odds of success compared to similarly qualified DOs (95% CI, 2.43–16.71; P < 0.01). Although MD applicants were evenly distributed across the quartiles, DO applicants were concentrated in the lowest quartile and were significantly less successful within this group. Conclusion: DO applicants with similar credentials to their MD counterparts have lower odds of matching into integrated plastic surgery, suggesting potential bias. However, disparities in overall scored metrics highlight areas to improve competitiveness.
- 4 October 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 95 (6) , 698-705
A Retrospective Comparative Analysis of MD and DO Applicants' Acceptance to Plastic Surgery Residency
Background: Doctor of osteopathic medicine (DO) applicants are underrepresented in integrated plastic surgery. We hypothesized they would match at a lower rate compared to similarly qualified doctor of medicine (MD) applicants. Methods: Applications to a large integrated plastic surgery residency program with a dedicated DO position were analyzed 2020–2023. Residents and faculty scored applications on research (1–5), letters of recommendation (LOR; 1–5), and USMLE Steps 1 and 2 (>240 = 1, >250 = 2), which summed to the total score. Residency match outcomes were verified online. Logistic regression modeling was used to assess MD versus DO odds of successful applications in the full dataset and a 3:1 MD-to-DO cohort matched by USMLE, research, and LOR scores. Applications were placed into quartiles based on total scores, and successful match outcomes were compared. Results: In the full dataset (MDs = 1100, DOs = 47), MDs had significantly stronger metrics ( P < 0.05) compared to DOs. In the adjusted logistic regression of the full dataset, MDs had 9.56 times the odds of success compared to DOs (95% CI, 3.84–27.62; P < 0.01). In the matched cohort, MDs had 5.89 times the odds of success compared to similarly qualified DOs (95% CI, 2.43–16.71; P < 0.01). Although MD applicants were evenly distributed across the quartiles, DO applicants were concentrated in the lowest quartile and were significantly less successful within this group. Conclusion: DO applicants with similar credentials to their MD counterparts have lower odds of matching into integrated plastic surgery, suggesting potential bias. However, disparities in overall scored metrics highlight areas to improve competitiveness.
- 25 September 2025
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 50 (11) , 1362-1369
Outcomes of Upper-Extremity Revascularization Following Acute Limb Ischemia
- 25 September 2025
- Published by Elsevier in The Journal of Hand Surgery
- Vol. 50 (11) , 1362-1369
Outcomes of Upper-Extremity Revascularization Following Acute Limb Ischemia